Geraldine T. Farrell, VP Operations, General Counsel at Nexvet Biopharma plc (NVET), sold 132 shares at $3.27 ($432) on 2016-03-03, disclosed to the SEC on 2016-03-17.
Open-market sale of $432 NVET by VP Operations, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.